Cargando…
Spermine and Citrate as Metabolic Biomarkers for Assessing Prostate Cancer Aggressiveness
Separating indolent from aggressive prostate cancer is an important clinical challenge for identifying patients eligible for active surveillance, thereby reducing the risk of overtreatment. The purpose of this study was to assess prostate cancer aggressiveness by metabolic profiling of prostatectomy...
Autores principales: | Giskeødegård, Guro F., Bertilsson, Helena, Selnæs, Kirsten M., Wright, Alan J., Bathen, Tone F., Viset, Trond, Halgunset, Jostein, Angelsen, Anders, Gribbestad, Ingrid S., Tessem, May-Britt |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3633894/ https://www.ncbi.nlm.nih.gov/pubmed/23626811 http://dx.doi.org/10.1371/journal.pone.0062375 |
Ejemplares similares
-
The genes controlling normal function of citrate and spermine secretion are lost in aggressive prostate cancer and prostate model systems
por: Rye, Morten Beck, et al.
Publicado: (2022) -
A novel non-canonical Wnt signature for prostate cancer aggressiveness
por: Sandsmark, Elise, et al.
Publicado: (2016) -
Presence of TMPRSS2-ERG is associated with alterations of the metabolic profile in human prostate cancer
por: Hansen, Ailin Falkmo, et al.
Publicado: (2016) -
Tissue Microstructure Is Linked to MRI Parameters and Metabolite Levels in Prostate Cancer
por: Selnæs, Kirsten Margrete, et al.
Publicado: (2016) -
Metabolic markers in blood can separate prostate cancer from benign prostatic hyperplasia
por: Giskeødegård, Guro F, et al.
Publicado: (2015)